Industry Insights
Mass Spectrometry in the Clinical Lab: The Importance of Choosing a Medical Device
Industry InsightIn this interview, SCIEX’s Francis Fung highlights the benefits that mass spectrometry can bring to clinical laboratories, and discusses why when selecting a mass spectrometer, it is important to consider choosing a medical device.
Read More
Exploring the Potential of Protein Degradation-focused Drug Discovery
Industry InsightUbiquigent's Jason Brown and Jason Mundin discuss the role of the ubiquitin cascade in cellular signaling and explain how it can be exploited to support protein degradation-focused drug discovery.
Read More
Thermo Fisher Scientific Joins the Pistoia Alliance
Industry InsightRecently, Thermo Fisher Scientific announced its membership of the Pistoia Alliance. At the Lab of the Future Congress 2019, we spoke with members of the Thermo Fisher team to learn more about the goals of joining the alliance, and what innovation means to Thermo Fisher.
Read More
Celebrations All Round for Analysis Veterans
Industry InsightAs a stalwart in the biological and chemical analysis fields, JEOL celebrates its 70th anniversary this year. But that’s not all it is celebrating, with the appointment of 35-year veteran of JEOL USA, Bob Pohorenec as President of the company this year.
Read More
How a Female Executive Became a Leader in the Business of Science
Industry InsightTrisha Rice, VP & GM Materials Science Business at Thermo Fisher Scientific, shares her experiences as a woman in science, and provides tips on how to be your most "authentic self" in the field.
Read More
Speed, Sensitivity, and High-throughput Analysis: The Latest Advancements in Metabolomics
Industry InsightTo find out more about the recent advances in metabolomics and the technologies that have evolved alongside it, we spoke with Lucy Woods, Global Technology Leader at Bruker Daltonics.
Read More
Fuelling Innovation in UK Life Sciences
Industry InsightWe spoke to Daniel Rooke, Head of Operations and Legal at Start Codon, to learn more about the company and how they can help early stage healthcare and life science businesses in the UK to get off the ground.
Read More
Translational Research in Clinical Proteomics
Industry InsightIn this article, Gary Kruppa, VP of Proteomics at Bruker Daltonics, explores how proteomic methods can help achieve the ultimate goal of preventing and improving the treatment of disease.
Read More
Method “Matches” Medicines to Their Unique Protein Receptors
Industry InsightA receptor (drug target) can shift from a single subunit to a multi-structure in the presence of a ligand (drug compound) – a process known as "oligomerization". Now, using photon excitation microscopy, researchers report that they can uncover the various protein receptor oligomers formed in the absence or presence of different drug candidates that bind to them.
Read More
A Conversation on the "Latest and Greatest" in Metabolomics
Industry InsightAided by advances in high-throughput technologies, the metabolomics research field has gained significant traction. We spoke with Baljit Ubhi, Ph.D. from SCIEX, about the recent developments in metabolomics, addressing the increasing focus on the microbiome, how it impacts metabolic disease, and the future directions of research, including "precision nutrition".
Read More
